粉样β改变了中介前额叶皮层对时间顺序任务编码的编码
Ignitius E Lim1, Ajn Vats1, Tashonda Vaughn1
1Department of Comparative Biomedical Sciences, Louisiana State University School of Veterinary Medicine, Baton Rouge, LA, USA.
Journal of Alzheimer's disease : JAD
|September 25, 2025
概括
阿尔茨海默病 (AD) 损害了时间顺序识别 (TOR) 记忆. 有毒的粉样蛋白-β (Aβ) 破坏了中间前额叶皮层的活动,阻碍了对象识别和对记忆编码至关重要的歧视.
科学领域:
- 神经科学是一个神经科学.
- 认知科学 认知科学
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,导致痴呆.
- 阿尔茨海默病的临床和实验性诊断发生在晚期,当症状明显时.
研究的目的:
- 调查时间顺序识别 (TOR) 编码在中间前额叶皮层.
- 在长期有毒或无毒的粉样β (Aβ) 病变期间检查48天内的变化.
主要方法:
- 利用*in vivo*在中部前额叶皮层的电生理记录.
- 在TOR任务中监控了假设的金字塔细胞发射率.
- 管理有毒的Aβ25-35或控制Aβ35-25病变.
主要成果:
- 在旧物体勘探过程中,TOR性能与单位火速变化呈正相关性.
- 在旧与最近的物体间隔期间,火速的增加更为普遍.
- 有毒的Aβ25-35病变取消了TOR性能-发射率相关性,并在旧物体探索过程中降低了单元活动.
结论:
- 毒性Aβ损伤通过改变中间前额叶皮层整体活动来破坏TOR记忆编码.
- 在有毒Aβ暴露后观察到受损的物体识别和歧视模式.
- 对照Aβ病变保持了单元发射速率和识别记忆之间的正相关性.
相关概念视频
Amyloid Fibrils
11.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.6K
Role of Amygdala in Memory
1.1K
The amygdala is a small, almond-shaped structure responsible for processing and storing memories, particularly those linked to emotions like fear and stress. It plays an essential role in the brain's response to emotionally significant events and often enhances memory formation by triggering stress hormone release. The amygdala is vital for encoding and retrieving memories associated with fear or stress, a process that is adaptive by helping organisms avoid dangerous situations.
One of the...
One of the...
1.1K
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K


